Search Results for gene therapy
You Might be Taking this Cholesterol Drug within a Few Years
Research - It’s been almost 30 years since the U.S. FDA approved the first statin to lower cholesterol, and the class remains the go-to therapy for treating hypercholesterolemia.
Premium
Sorrento Divests of its Lead Drug – to its Biggest Shareholder
Insights - Sorrento Therapeutics (SRNE) has sold lead drug candidate Cynviloq to NantPharma, founded by healthcare entrepreneur & SRNE’s largest investor, Patrick Soon-Shiong, and a subsidiary of partner NantWorks. Sorrento … Continue Reading
Read now
What Makes Affimed An Interesting – albeit Under-followed – Drug Developer
Research - Completing their IPO in September 2014 and raising $56 million, Affimed Therapeutics (AFMD) is a German clinical-stage biopharmaceutical company developing targeted cancer immunotherapies. Affimed’s product … Continue Reading
Read now
Aduro is the Latest – and Hottest – Oncology IPO
Insights - Aduro Biotech (ADRO) begins trading on Wednesday morning at 10:25 ET having completed a $119 million IPO that values the immunotherapy company at just over … Continue Reading
Read now
A Heavy Dose of M&A this Week in Healthcare
Uh oh. Bubble Talk is Back in Biotech
Recap - Healthcare stocks were routed early this week, falling 10% (based on the NASDAQ Biotech Index) before a bounce from mid-week into Friday. The similarities to … Continue Reading
Read now